Trial · NCT00315302
Participant flow28
How many started, completed or left each group, period by period.
1 to 20 of 28
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Atropine-Moderate Amblyopia | 90 | |
| Overall Study | STARTED | Atropine Plus Plano-Moderate Amblyopia | 90 | |
| Overall Study | STARTED | Atropine-Severe Amblyopia | 26 | |
| Overall Study | STARTED | Atropine Plus Plano-Severe Amblyopia | 34 | |
| Overall Study | 5 Week Visit | Atropine-Moderate Amblyopia | 85 | |
| Overall Study | 5 Week Visit | Atropine Plus Plano-Moderate Amblyopia | 86 | |
| Overall Study | 5 Week Visit | Atropine-Severe Amblyopia | 26 | |
| Overall Study | 5 Week Visit | Atropine Plus Plano-Severe Amblyopia | 30 | |
| Overall Study | 10 Week Visit | Atropine-Moderate Amblyopia | 86 | |
| Overall Study | 10 Week Visit | Atropine Plus Plano-Moderate Amblyopia | 85 | |
| Overall Study | 10 Week Visit | Atropine-Severe Amblyopia | 24 | |
| Overall Study | 10 Week Visit | Atropine Plus Plano-Severe Amblyopia | 29 | |
| Overall Study | 18 Week Primary Outcome Visit | Atropine-Moderate Amblyopia | 84 | |
| Overall Study | 18 Week Primary Outcome Visit | Atropine Plus Plano-Moderate Amblyopia | 88 | |
| Overall Study | 18 Week Primary Outcome Visit | Atropine-Severe Amblyopia | 24 | |
| Overall Study | 18 Week Primary Outcome Visit | Atropine Plus Plano-Severe Amblyopia | 31 | |
| Overall Study | Partial Responder Phase (Post 18 Weeks) | Atropine-Moderate Amblyopia | 16 | |
| Overall Study | Partial Responder Phase (Post 18 Weeks) | Atropine Plus Plano-Moderate Amblyopia | 13 | |
| Overall Study | Partial Responder Phase (Post 18 Weeks) | Atropine-Severe Amblyopia | 9 | |
| Overall Study | Partial Responder Phase (Post 18 Weeks) | Atropine Plus Plano-Severe Amblyopia | 11 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00315302/flow